Dolby Laboratories, Inc.
DLBNYSETechnology● Active
$53.78
$-0.26(-0.48%)
Market Cap$5.1B
P/E Ratio—
52W High$77
52W Low$52.45
Dolby Laboratories, Inc. (DLB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DLB · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$1.37
Est. $1.31 · +4.6%
Revenue
$0.40B
Est. $0.39B · +2.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 11-Quarter EPS Beat Streak
DLB reports quarterly as a NYSE-listed Information Technology Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $0.67 | — | — | — | $0.31B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $1.31 | $1.37 | +4.6% | $0.40B | $0.39B | +2.5% |
| ▲ Q1 FY2026 | Jan 29, 2026 | $0.99 | $1.06 | +6.8% | $0.35B | $0.34B | +1.6% |
| ▲ Q4 FY2025 | Nov 18, 2025 | $0.70 | $0.99 | +41.6% | $0.31B | $0.31B | +0.4% |
| ▲ Q3 FY2025 | Jul 31, 2025 | $0.71 | $0.78 | +9.2% | $0.32B | $0.31B | +3.2% |
| ▲ Q2 FY2025 | May 1, 2025 | $1.27 | $1.34 | +5.5% | $0.37B | $0.31B | +21.1% |
| ▲ Q1 FY2025 | Jan 29, 2025 | $1.12 | $1.14 | +1.8% | $0.36B | $0.38B | -7.0% |
| ▲ Q4 FY2024 | Nov 19, 2024 | $0.70 | $0.81 | +15.7% | $0.30B | $0.31B | -1.0% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$0.67
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$1.37
EPS Est.
$1.31
EPS Surpr.
+4.6%
Revenue
$0.40B
Q1 FY2026
Jan 29, 2026Beat
EPS Actual
$1.06
EPS Est.
$0.99
EPS Surpr.
+6.8%
Revenue
$0.35B
Q4 FY2025
Nov 18, 2025Beat
EPS Actual
$0.99
EPS Est.
$0.70
EPS Surpr.
+41.6%
Revenue
$0.31B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
$0.78
EPS Est.
$0.71
EPS Surpr.
+9.2%
Revenue
$0.32B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$1.34
EPS Est.
$1.27
EPS Surpr.
+5.5%
Revenue
$0.37B
Q1 FY2025
Jan 29, 2025Beat
EPS Actual
$1.14
EPS Est.
$1.12
EPS Surpr.
+1.8%
Revenue
$0.36B
Q4 FY2024
Nov 19, 2024Beat
EPS Actual
$0.81
EPS Est.
$0.70
EPS Surpr.
+15.7%
Revenue
$0.30B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $1.40 | $1.44 | $1.47 | 1 |
| Q2 FY2028 | $0.97 | $1.00 | $1.02 | 1 |
| Q1 FY2028 | $1.38 | $1.42 | $1.45 | 1 |
| Q4 FY2027 | $1.15 | $1.18 | $1.21 | 1 |
| Q3 FY2027 | $1.12 | $1.15 | $1.18 | 1 |
| Q2 FY2027 | $0.92 | $0.95 | $0.97 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 2 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 2 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +4.6% | $63.26 | $64.14 | +1.39% |
| ▲ Q1 FY2026 | Jan 29, 2026 | +6.8% | $61.19 | $63.03 | +3.01% |
| ▲ Q4 FY2025 | Nov 18, 2025 | +41.6% | $64.55 | $64.96 | +0.64% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +9.2% | $75.73 | $75.34 | -0.51% |
| ▲ Q2 FY2025 | May 1, 2025 | +5.5% | $76.79 | $76.18 | -0.79% |
| ▲ Q1 FY2025 | Jan 29, 2025 | +1.8% | $80.61 | $80.63 | +0.02% |
| ▲ Q4 FY2024 | Nov 19, 2024 | +15.7% | $71.35 | $70.91 | -0.62% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +132.8% | $73.57 | $73.22 | -0.48% |
Q2 FY2026+1.39%
Report Date
Apr 30, 2026
EPS Beat/Miss
+4.6%
Price Before
$63.26
Price After
$64.14
Q1 FY2026+3.01%
Report Date
Jan 29, 2026
EPS Beat/Miss
+6.8%
Price Before
$61.19
Price After
$63.03
Q4 FY2025+0.64%
Report Date
Nov 18, 2025
EPS Beat/Miss
+41.6%
Price Before
$64.55
Price After
$64.96
Q3 FY2025-0.51%
Report Date
Jul 31, 2025
EPS Beat/Miss
+9.2%
Price Before
$75.73
Price After
$75.34
Q2 FY2025-0.79%
Report Date
May 1, 2025
EPS Beat/Miss
+5.5%
Price Before
$76.79
Price After
$76.18
Q1 FY2025+0.02%
Report Date
Jan 29, 2025
EPS Beat/Miss
+1.8%
Price Before
$80.61
Price After
$80.63
Q4 FY2024-0.62%
Report Date
Nov 19, 2024
EPS Beat/Miss
+15.7%
Price Before
$71.35
Price After
$70.91
Q3 FY2024-0.48%
Report Date
Aug 7, 2024
EPS Beat/Miss
+132.8%
Price Before
$73.57
Price After
$73.22
Avg Beat Reaction+0.33%
Beat Rate8 / 8 quarters
Largest Move+3.01% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DLB ends December
Dolby Laboratories, Inc. (DLB) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $1.37 — beating the analyst consensus of $1.31 by +4.6%. DLB has beaten EPS estimates for 11 consecutive quarters. The next DLB earnings date is expected around September 1, 2026.
Each quarter, investors track DLB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DLB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DLB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DLB earnings · 5 questionsDolby Laboratories, Inc.'s next earnings report is expected around September 1, 2026. DLB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DLB historically reports after market close (AMC).
DLB earnings datewhen is DLB earningsDLB next earnings datewhen does DLB report earningsDLB earnings calendar
▸ Source: FMP · Dolby Laboratories, Inc. SEC filings · US GAAP · Dolby Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026